Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.1.6 (
CAD
)
4,420
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Background
- In this study, we aimed to investigate functional mechanisms underlying
CAD
loci, and find molecular biomarkers for
CAD
.
Methods
- We devised a multiomics data analysis approach based on Mendelian randomization and utilized it to search for molecular biomarkers causally associated with the risk of
CAD
within genomic regions known to be associated with
CAD
.
Results
- Through our
CAD
-centered multiomics data analysis approach, we identified 33 molecular biomarkers (probes) that were causally associated with the risk of
CAD
. The majority of these (N=19) were methylation probes; moreover, methylation was often behind the causal effect of expression/protein probes. We identified a number of novel loci that have a causal impact on
CAD
including
C5orf38
,
SF3A3
,
DHX36
and
MRPL33
. Furthermore, by integrating the risk factors of
CAD
in our analysis, we were able to investigate the clinical pathways whereby several of our probes exert their effect. We found that the SELE protein level in the blood is under the
trans
-regulatory impact of methylation sites within the
ABO
gene and that SELE exerts its effect on
CAD
through immune, glycemic, and lipid metabolism, making it a candidate of interest for therapeutic interventions. We found the methylation site, cg05126514 within the
BSN
gene exert its effect on
CAD
through CNS-life style risk factors. Finally, genes with a transcriptional regulatory role (
SF3A3
,
ILF3
and
N4BP2L2
) exert their effect on
CAD
through height.
Conclusions
- We demonstrate that multiomics data analysis is a powerful approach to unravel the functional mechanisms underlying
CAD
loci and to identify novel molecular biomarkers. Our results indicate epigenetic modifications are important in the pathogenesis of
CAD
and identifying and targeting these sites is of potential therapeutic interest to address the detrimental effects of both environmental and genetic factors.
...
PMID:Multiomics Screening Identifies Molecular Biomarkers Causally Associated with the Risk of Coronary Artery Disease. 3296 17